Term Gallery logo

Significados de susceptibility to multiple system atrophy 1 em inglês

russo
синдром шая — дрейджера
português
atrofia de múltiplos sistemas
catalão
atròfia multisistèmica
espanhol
atrofia multisistémica

Multiple system atrophy (MSA) is a neurodegenerative disorder characterized by autonomic failure (cardiovascular and/or urinary), parkinsonism, cerebellar impairment and corticospinal signs with a median survival of 6-9 years.

Veja mais
atrofia de múltiplos sistemas
Sinônimos
Examples for "msa"
Examples for "msa"
1
This article reports the validation of the German translation of the MSA-QoL.
Pubmed
2
Conclusions: This is the largest study of OH in patients with MSA.
Pubmed
3
Preliminary research on short-term outcomes after MSA demonstrated significant regression of Barrett's.
Pubmed
4
Furthermore, MSA had no effect on this enzyme in all tested tissues.
Pubmed
5
Estimated county-level MSM counts were aggregated to form MSA- and state-level totals.
Pubmed
1
In contrast to AD, NGF receptor-containing cortical neurons were not observed in Parkinson disease, Pick disease, or Shy-Drager syndrome.
Pubmed
1
All the patients with multiple system atrophy had hyperreflexia with synergy.
Pubmed
2
A diagnosis of multiple system atrophy was made, supported by MRI findings and evidence of autonomic dysfunction.
Pubmed
3
Urodynamic findings may be abnormal before patients with multiple system atrophy reach an advanced stage of the disease.
Pubmed
4
Degenerative processes of disease-specific tracts were clearly identified as illustrated in cases of multiple system atrophy and Joseph-Machado disease.
Pubmed
5
Objective: To explore the prognostic factors for inability to walk independently in patients with multiple system atrophy (MSA).
Pubmed